Summary of Product Characteristics
last updated on the eMC:
01/02/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 01/02/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 08/01/2010 and displayed until 01/02/2010
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 date of revision of the text
|
|
Updated on 27/10/2009 and displayed until 08/01/2010
|
Reasons for adding or updating:
|
-
Change to section 6.1 - List of Excipients
|
|
Updated on 19/09/2006 and displayed until 27/10/2009
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contra-indications
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 9 - Date of Renewal of Authorisation
|
|
Updated on 11/10/2005 and displayed until 19/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 23/08/2001 and displayed until 11/10/2005
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|
Updated on 06/09/1999 and displayed until 23/08/2001
|
Reasons for adding or updating:
|
|
|
|